Total Funding
58
62
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
168224
AROMICS is committed to the discovery and development of novel drugs and diagnostic methods to target relevant human health diseases.
- Carme Plasencia: Owner & CEOPast Role: University of Southern California, Research Assistant
- Narcís Clavell: Co-Founder & Investor
About the Company
AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.
They believe that OMIC technologies represent an important first step towards gaining biological insights into:
How drugs work, giving them added value, reducing
attrition rates and advancing through the clinic. Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.
